1. Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. (17th December 2018) Authors: Rule, Simon; Cook, Gordon; Russell, Nigel H.; Hunter, Ann; Robinson, Stephen; Morley, Nick; Sureda, Anna; Patrick, Pip; Clifton‐Hadley, Laura; Adedayo, Toyin; Kirkwood, Amy; Peggs, Karl S. Journal: British journal of haematology Issue: Volume 184:Number 6(2019) Page Start: 999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bortezomib consolidation post‐ASCT as frontline therapy for multiple myeloma deepens disease response and MRD‐negative rate whilst maintaining QOL and response to re‐treatment at relapse. (20th November 2018) Authors: Cohen, Oliver C.; Counsell, Nicholas; Rabin, Neil; Popat, Rakesh; Owen, Roger G.; Popova, Bilyana; Schofield, Oliver; Clifton‐Hadley, Laura; Lyons‐Lewis, Janet; Rawstron, Andy; Spence, Christopher; de Tute, Ruth M.; Hughes, Derralynn; Moore, Sally; Smith, Paul; Yong, Kwee L. Journal: British journal of haematology Issue: Volume 185:Number 5(2019) Page Start: 948 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial. (21st November 2020) Authors: Camilleri, Marquita; Sive, Jonathan; Wilson, William; Pang, Gavin; Jenner, Richard; Phillips, Elizabeth; Popat, Rakesh; Ramasamy, Karthik; Bygrave, Ceri; Dadaga, Tushhar; Streetly, Matthew; Cavenagh, James; Chapman, Mike; Barrington, Sally; Pike, Lucy; Owen, Roger; Clifton‐Hadley, Laura; Yong, Kwee Journal: British journal of haematology Issue: Volume 192:Number 1(2021) Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial. Issue 1 (29th April 2020) Authors: Phillips, Elizabeth H.; Burton, Catherine; Kirkwood, Amy A.; Barrans, Sharon; Lawrie, Anthony; Rule, Simon; Patmore, Russell; Pettengell, Ruth; Ardeshna, Kirit M.; Montoto, Silvia; Paneesha, Shankara; Clifton‐Hadley, Laura; Linch, David C.; McMillan, Andrew K. Journal: EJHaem Issue: Volume 1:Issue 1(2020) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial. Issue 1 (29th April 2020) Authors: Phillips, Elizabeth H.; Burton, Catherine; Kirkwood, Amy A.; Barrans, Sharon; Lawrie, Anthony; Rule, Simon; Patmore, Russell; Pettengell, Ruth; Ardeshna, Kirit M.; Montoto, Silvia; Paneesha, Shankara; Clifton‐Hadley, Laura; Linch, David C.; McMillan, Andrew K. Journal: EJHaem Issue: Volume 1:Issue 1(2020) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial. Issue 1 (29th April 2020) Authors: Phillips, Elizabeth H.; Burton, Catherine; Kirkwood, Amy A.; Barrans, Sharon; Lawrie, Anthony; Rule, Simon; Patmore, Russell; Pettengell, Ruth; Ardeshna, Kirit M.; Montoto, Silvia; Paneesha, Shankara; Clifton‐Hadley, Laura; Linch, David C.; McMillan, Andrew K. Journal: EJHaem Issue: Volume 1:Issue 1(2020) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study. (4th July 2020) Authors: Mikhaeel, N. George; Cunningham, David; Counsell, Nicholas; McMillan, Andrew; Radford, John A.; Ardeshna, Kirit M.; Lawrie, Anthony; Smith, Paul; Clifton‐Hadley, Laura; O'Doherty, Michael J.; Barrington, Sally F. Journal: British journal of haematology Issue: Volume 192:Number 3(2021) Page Start: 504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial. (11th October 2021) Authors: Chan, Wei Yee; Counsell, Nicholas; de Tute, Ruth; De‐Silva, Dunnya; Phillips, Elizabeth H.; Cavenagh, Jamie; Adedayo, Toyin; Braganca, Nivette; Roddie, Claire; Streetly, Matthew; Schey, Stephen; Koh, Mickey B.C.; Crowe, Josephine; Morris, Treen C.; Cook, Gordon; Clifton‐Hadley, Laura; Rabin, Neil... Other Names: D'Sa Shirley investigator.; Virchis Andres investigator.; Quinn Michael investigator.; Crawley Charles investigator.; Pratt Guy investigator.; Cook Mark investigator. Journal: British journal of haematology Issue: Volume 196:Number 4(2022) Page Start: e33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostic indices in diffuse large B‐cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R‐CHOP 14 versus 21 phase 3 trial. (20th May 2020) Authors: Gleeson, Mary; Counsell, Nicholas; Cunningham, David; Lawrie, Anthony; Clifton‐Hadley, Laura; Hawkes, Eliza; McMillan, Andrew; Ardeshna, Kirit M.; Burton, Cathy; Chadwick, Nick; Gambell, Joanna; Smith, Paul; Mouncey, Paul; Pocock, Christopher; Radford, John; Davies, John; Turner, Deborah; Kruger,... Journal: British journal of haematology Issue: Volume 192:Number 6(2021) Page Start: 1015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Relapse patterns in early‐PET negative, limited‐stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy–a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials. (21st December 2022) Authors: Fiaccadori, Valeria; Neven, Anouk; Fortpied, Catherine; Aurer, Igor; Andre, Marc; Federico, Massimo; Counsell, Nicholas; Phillips, Elizabeth H.; Clifton‐Hadley, Laura; Barrington, Sally F.; Illidge, Timothy; Radford, John; Raemaekers, John M. M. Journal: British journal of haematology Issue: Volume 200:Number 6(2023) Page Start: 731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗